Enzo Biochem, Inc. announced that it has entered into Securities Purchase Agreement with each of the purchasers and new investor, JGB Collateral, LLC to issue 10% Original Issue Discount Secured Convertible Debentures with an aggregate principal amount of $7,608,696 on May 19, 2023. The company will also issue warrants to purchase up to 1,000,000 shares of the Company?s common stock, par value $0.01 per share for an exercise price of $2.31 per share, the average of the 3 daily volume weighted average prices of the common stock as defined in the Purchase Agreement prior to the closing date, subject to adjustments as set forth in the warrants, for a total purchase price of $7,000,000. The Purchase Agreement contains customary representations, warranties and covenants.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -1.87% | -3.67% | -24.46% |
1st Jan change | Capi. | |
---|---|---|
-24.46% | 53.79M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ENZ Stock
- News Enzo Biochem, Inc.
- Enzo Biochem, Inc. announced that it expects to receive $7.608696 million in funding from JGB Collateral, LLC